Chemomab Therapeutics logo

Chemomab Therapeutics

CMMB | NASDAQ
Chart Builder DCF Calculator
$1.62
+$0.09 (+5.88%)
At close: Nov 16, 2026, 4:00 PM ET
$1.62
$0.00 (+0.15%)
After-hours: Nov 16, 2026, 5:32 PM ET
+5.88%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
32
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #745/1021 (Top 73%)

Key Statistics

Market Data

Market Cap $12.96M
1D Range
1.50 1.68
52W Range
1.00 2.83

Valuation (TTM)

PE -1.59
PB 1.49
EV/EBITDA -0.79

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $0.00
Loading financial charts...

Profile

Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions. Its leading experimental d...

Sector Healthcare
Industry Biotechnology
Employees 12
IPO Date Feb 12, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.